HOME >> BIOLOGY >> NEWS
Largest synthetic gene ever built offers insights into anti-malarial drug resistance

Washington, DC -- Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades. They have been able to artificially construct, and then express in yeast, a protozoan gene that contributes to such resistance. And it was no small feat. The gene they laboriously constructed over a two-year period is believed to be the largest “synthetic” one ever built, and it successfully produces large quantities of the encoded protein, whose function can now be easily studied.

In research published in the May 22 issue of the journal Biochemistry, the researchers say that with the addition of the recreated gene, PfMDR1 and its protein, they have all the biomolecular tools necessary to molecularly understand how the malarial parasite Plasmodium falciparum (P. falciparum), has become resistant to most of the drugs that could once destroy it. They have already described and expressed two other genes known to confer drug resistance.

"Now that we have these genes expressed in a convenient yeast system, we can work to understand the molecular basis of anti-malarial drug resistance, providing insight into how future drugs might be designed to effectively kill the parasite," said Paul Roepe, Ph.D., a professor in the Department of Biochemistry and Cellular & Molecular Biology as well as the Department of Chemistry.

Any animal with red blood cells can develop malaria, which is caused by a single-cell protozoan parasite transmitted by the bite of the female Anopheles mosquito. There are about 160 different species of malaria parasites, according to Roepe. Five infect humans, but P. falciparum is responsible for about 1 million deaths out of 300 million acute cases of infection each year. Most of these deaths occur in young children living in sub-Saharan Africa.

Roepe and his collaborators at Georgetown Univers
'"/>

Contact: Laura Cavender
lsc6@georgetown.edu
202-687-5100
Georgetown University Medical Center
6-Jun-2007


Page: 1 2 3 4

Related biology news :

1. Largest ever study of genetics of common diseases published today
2. Largest physics meeting of the year, in Denver
3. Largest-ever search for autism genes reveals new clues
4. Largest genomic search finds genes that may contribute to autism
5. Largest study of human interactome reveals a novel way
6. Scientists call for global push to advance research in synthetic biology
7. New synthetic self-assembling macromolecules mimic nature
8. Williams College biologist explores photosynthetic apparatus
9. Scientists identify synthetic compound that keeps stem cells young
10. Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice
11. Early exposure to synthetic estrogen puts DES Daughters at higher risk for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... (PRWEB) , ... May 16, 2019 , ... SFC ... as part of the Industry Development and Discovery Partnership that was awarded to SFC ... of a single integrated pod artificial pancreas (AP) system for people with type 1 ...
(Date:5/14/2019)... ... May 14, 2019 , ... IMMUNE 3D®, ... beyond immuno-oncology into areas of autoimmunity, fibrosis and skin immunology. In addition, the ... lines for IO discovery efforts. , IMMUNE 3D®’s proprietary platform aims to ...
(Date:5/14/2019)... ... 13, 2019 , ... NRD, LLC is excited to announce ... 15-16, 2019, the largest medical technology event in the Northeast serving over 3,300+ ... product organizations. , They will be displaying their latest technologies, including a “sneak ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ALISO VIEJO, Calif. (PRWEB) , ... May 02, ... ... a leading clinical genetics testing company, will present results documenting discrepancies between U.S. ... medical management guidelines for patients at risk for hereditary breast and ovarian cancer ...
(Date:4/16/2019)... ... April 16, 2019 , ... On April ... partner, the U.S. Army Center for Environmental Health Research (USACEHR), with an award ... , Blue Sources, a veteran-owned company located at the Frederick Innovative Technology Center, ...
(Date:4/10/2019)... , ... April 10, 2019 , ... After more than ... The new kitchen is equipped with updated appliances and modern lighting and fixtures, ... Jolla-based venue. , “We’ve seen tremendous growth in the demand for our ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities , ... preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 ... targeted at female hypoactive sexual dysfunction disorder and is ready to begin phase 2b ...
Breaking Biology Technology:
Cached News: